TNFRSF10B and neoplasm: Thus, the expression levels of TRAIL receptors as well as the preference for the usage of TRAIL-R1 or TRAIL-R2 in TRAIL-induced apoptotic/non-apoptotic signaling may be an essential factor determining both, the tumor initiation and progression.